| | Title | Authors / Editors | Date |
|
unige:21160 |
Treatment of osteoporosis: recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity |
Musette, P.; Brandi, M. L.; Cacoub, P.; Kaufman, J. M.; ... Reginster, J-Y |
2010 |
|
unige:20810 |
Relationship between 3-month changes in biochemical markers of bone remodelling and changes in bone mineral density and fracture incidence in patients treated with strontium ranelate for 3 years |
Bruyere, O.; Collette, J.; Rizzoli, René; Decock, C.; ... Reginster, J-Y |
2010 |
|
unige:20811 |
The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES) |
Bruyere, O.; Kanis, J. A.; Ibar-Abadie, M-E; Alsayed, N.; ... Reginster, J-Y |
2010 |
|
unige:19751 |
The International Osteoporosis Foundation: history, objectives and achievements |
Cooper, C.; Rizzoli, René; Reginster, J-Y |
2009 |
|
unige:19079 |
Post-fracture management of patients with hip fracture: a perspective |
Bruyere, O.; Brandi, M-L; Burlet, N.; Harvey, N.; ... Akesson, K. |
2008 |
Reginster, J-Y
add all
remove all
